Search Results - "van Leeuwen, Leanne P. M."

Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals by Zaeck, Luca M., Lamers, Mart M., Verstrepen, Babs E., Bestebroer, Theo M., van Royen, Martin E., Götz, Hannelore, Shamier, Marc C., van Leeuwen, Leanne P. M., Schmitz, Katharina S., Alblas, Kimberley, van Efferen, Suzanne, Bogers, Susanne, Scherbeijn, Sandra, Rimmelzwaan, Guus F., van Gorp, Eric C. M., Koopmans, Marion P. G., Haagmans, Bart L., GeurtsvanKessel, Corine H., de Vries, Rory D.

“…In July 2022, the ongoing monkeypox (MPX) outbreak was declared a public health emergency of international concern. Modified vaccinia Ankara—Bavarian Nordic…”
Get full text

Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial by Tan, Ngoc H, Geers, Daryl, Sablerolles, Roos S G, Rietdijk, Wim J R, Goorhuis, Abraham, Postma, Douwe F, Visser, Leo G, Bogers, Susanne, van Dijk, Laura L A, Gommers, Lennert, van Leeuwen, Leanne P M, Boerma, Annemarie, Nijhof, Sander H, van Dort, Karel A, Koopmans, Marion P G, Dalm, Virgil A S H, Lafeber, Melvin, Kootstra, Neeltje A, Huckriede, Anke L W, van Baarle, Debbie, Zaeck, Luca M, GeurtsvanKessel, Corine H, de Vries, Rory D, van der Kuy, P Hugo M

“…Bivalent mRNA-based COVID-19 vaccines encoding the ancestral and omicron spike (S) protein were developed as a countermeasure against antigenically distinct…”
Get full text

A beacon in the dark: COVID-19 course in CVID patients from two European countries: Different approaches, similar outcomes by Milito, Cinzia, Firinu, Davide, Bez, Patrick, Villa, Annalisa, Punziano, Alessandra, Lagnese, Gianluca, Costanzo, Giulia, van Leeuwen, Leanne P M, Piazza, Beatrice, Deiana, Carla Maria, d'Ippolito, Giancarlo, Del Giacco, Stefano Renato, Rattazzi, Marcello, Spadaro, Giuseppe, Quinti, Isabella, Scarpa, Riccardo, Dalm, Virgil A S H, Cinetto, Francesco

“…CVID patients present an increased risk of prolonged SARS-CoV-2 infection and re-infection and a higher COVID-19-related morbidity and mortality compared to…”
Get full text

Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program by van Leeuwen, Leanne P M, Grobben, Marloes, GeurtsvanKessel, Corine H, Ellerbroek, Pauline M, de Bree, Godelieve J, Potjewijd, Judith, Rutgers, Abraham, Jolink, Hetty, van de Veerdonk, Frank L, van Gils, Marit J, de Vries, Rory D, Dalm, Virgil A S H

“…Previous studies have demonstrated that the majority of patients with an inborn error of immunity (IEI) develop a spike (S)-specific IgG antibody and T-cell…”
Get full text

Evaluation of the Hepatitis B Vaccination Programme in Medical Students in a Dutch University Hospital by van Leeuwen, Leanne P M, Doornekamp, Laura, Goeijenbier, Simone, de Jong, Wesley, de Jager, Herbert J, van Gorp, Eric C M, Goeijenbier, Marco

“…Healthcare workers (HCW) are at increased risk of contracting hepatitis B virus (HBV) and are, therefore, vaccinated pre-exposure. In this study, the HBV…”
Get full text

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity by van Leeuwen, Leanne P.M., GeurtsvanKessel, Corine H., Ellerbroek, Pauline M., de Bree, Godelieve J., Potjewijd, Judith, Rutgers, Abraham, Jolink, Hetty, van de Veerdonk, Frank, van Gorp, Eric C.M., de Wilt, Faye, Bogers, Susanne, Gommers, Lennert, Geers, Daryl, Bruns, Anke H.W., Leavis, Helen L., van Haga, Jelle W., Lemkes, Bregtje A., van der Veen, Annelou, de Kruijf-Bazen, S.F.J., van Paassen, Pieter, de Leeuw, Karina, van de Ven, Annick A.J.M., Verbeek-Menken, Petra H., van Wengen, Annelies, Arend, Sandra M., Ruten-Budde, Anja J., van der Ent, Marianne W., van Hagen, P. Martin, Sanders, Rogier W., Grobben, Marloes, van der Straten, Karlijn, Burger, Judith A., Poniman, Meliawati, Nierkens, Stefan, van Gils, Marit J., de Vries, Rory D., Dalm, Virgil A.S.H.

“…Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective vaccination against COVID-19 is…”
Get full text

Exotic viral hepatitis: A review on epidemiology, pathogenesis, and treatment by van Leeuwen, Leanne P.M., de Jong, Wesley, Doornekamp, Laura, van Gorp, Eric C.M., Wismans, Pieter J., Goeijenbier, Marco

“…Certain “exotic” viruses are known to cause clinical diseases with potential liver involvement. These include viruses, beyond regular hepatotropic viruses…”
Get full text

Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters by Zaeck, Luca M., Tan, Ngoc H., Rietdijk, Wim J. R., Geers, Daryl, Sablerolles, Roos S. G., Bogers, Susanne, van Dijk, Laura L. A., Gommers, Lennert, van Leeuwen, Leanne P. M., Rugebregt, Sharona, Goorhuis, Abraham, Postma, Douwe F., Visser, Leo G., Dalm, Virgil A. S. H., Lafeber, Melvin, Kootstra, Neeltje A., Huckriede, Anke L. W., Haagmans, Bart L., van Baarle, Debbie, Koopmans, Marion P. G., van der Kuy, P. Hugo M., GeurtsvanKessel, Corine H., de Vries, Rory D.

“…Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a…”
Get full text

Immune Responses 6 Months After mRNA-1273 COVID-19 Vaccination and the Effect of a Third Vaccination in Patients with Inborn Errors of Immunity by van Leeuwen, Leanne P. M., Grobben, Marloes, GeurtsvanKessel, Corine H., Ellerbroek, Pauline M., de Bree, Godelieve J., Potjewijd, Judith, Rutgers, Abraham, Jolink, Hetty, van de Veerdonk, Frank L., van Gils, Marit J., de Vries, Rory D., Dalm, Virgil A. S. H.

“…Purpose Patients with inborn errors of immunity (IEI) are at increased risk of severe coronavirus disease-2019 (COVID-19). Effective long-term protection…”
Get full text

Orthopoxvirus-specific antibodies wane to undetectable levels 1 year after MVA-BN vaccination of at-risk individuals, the Netherlands, 2022 to 2023 by van Leeuwen, Leanne Pm, Shamier, Marc C, Verstrepen, Babs E, Götz, Hannelore M, Schmitz, Katharina S, Akhiyate, Najlae, Wijnans, Koen, Bogers, Susanne, van Royen, Martin E, van Gorp, Eric Cm, Koopmans, Marion Pg, de Vries, Rory D, GeurtsvanKessel, Corine H, Zaeck, Luca M

“…In response to the mpox outbreak in 2022 and 2023, widespread vaccination with modified vaccinia Ankara-Bavarian Nordic (MVA-BN, also known as JYNNEOS or…”
Get full text

Modern methods for the development of antiviral vaccines by Raadsen, Matthijs P, van Leeuwen, Leanne P M, van Gorp, Eric C M, de Swart, Rik L, Haagmans, Bart L

“…Antiviral vaccines have contributed substantially to a reduction in the morbidity and mortality suffered from viral infectious diseases, especially during the…”
Get more information